Institutional shares held 65.4 Million
228K calls
772K puts
Total value of holdings $94.2M
$328K calls
$1.11M puts
Market Cap $70.1M
48,682,000 Shares Out.
Institutional ownership 134.41%
# of Institutions 168


Latest Institutional Activity in PLRX

Top Purchases

Q1 2025
Peapod Lane Capital LLC Shares Held: 642K ($925K)
Q1 2025
High Mark Wealth Management LLC Shares Held: 158K ($227K)
Q1 2025
Sg Americas Securities, LLC Shares Held: 40.6K ($58.5K)
Q1 2025
Cwm, LLC Shares Held: 8.53K ($12.3K)
Q1 2025
Gf Fund Management Co. Ltd. Shares Held: 1.51K ($2.17K)

Top Sells

Q1 2025
Rice Hall James & Associates, LLC Shares Held: 153K ($220K)
Q1 2025
Hennion & Walsh Asset Management, Inc. Shares Held: 104K ($150K)
Q1 2025
Alps Advisors Inc Shares Held: 45.3K ($65.2K)
Q1 2025
Rhumbline Advisers Shares Held: 89.7K ($129K)
Q1 2025
Teacher Retirement System Of Texas Shares Held: 12.5K ($18K)

About PLRX

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.


Insider Transactions at PLRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
521K Shares
From 6 Insiders
Grant, award, or other acquisition 521K shares
Sell / Disposition
214K Shares
From 6 Insiders
Open market or private sale 214K shares

Track Institutional and Insider Activities on PLRX

Follow PLIANT THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLRX shares.

Notify only if
Any

Insider Trading

Get notified when an Pliant Therapeutics, Inc. insider buys or sells PLRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to PLIANT THERAPEUTICS, INC.

Track Activities on PLRX